Ali AT, Al-ani O, Al-ani F. Epidemiology and risk factors for ovarian cancer. Menopause Review/Przegląd Menopauzalny. 2023;22(2):93–104.
Konstantinopoulos PA, Matulonis UA. Clinical and translational advances in ovarian cancer therapy. Nat Cancer. 2023;4(9):1239–57.
Reid F, Bhatla N, Oza AM, Blank SV, Cohen R, Adams T, et al. The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life. Int J Gynecologic Cancer. 2021;31(2):238–44.
Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.
Article PubMed PubMed Central Google Scholar
Kurman RJ, Shih Ie M. The Dualistic Model of ovarian carcinogenesis: revisited, revised, and expanded. Am J Pathol. 2016;186(4):733–47.
Article PubMed PubMed Central Google Scholar
Nero C, Ciccarone F, Pietragalla A, Duranti S, Daniele G, Salutari V, et al. Ovarian Cancer treatments Strategy: focus on PARP inhibitors and Immune check point inhibitors. Cancers. 2021;13(6):1298.
Article CAS PubMed PubMed Central Google Scholar
Capozzi VA, Rosati A, Turco LC, Sozzi G, Riccò M, Chiofalo B, Vizzielli G. Surgery vs. chemotherapy for ovarian cancer recurrence: what is the best treatment option. Gland Surg. 2020;9(4):1112–7.
Article PubMed PubMed Central Google Scholar
Yang C, Kim HS, Song G, Lim W. The potential role of exosomes derived from ovarian cancer cells for diagnostic and therapeutic approaches. J Cell Physiol. 2019;234(12):21493–503.
Article CAS PubMed Google Scholar
Zhou L, Min Y, Cao Q, Tan X, Cui Y, Wang J. Comprehensive analysis of the value of angiogenesis and stemness-related genes in the prognosis and immunotherapy of ovarian cancer. BioFactors. 2025;51(1):e2155.
Article CAS PubMed Google Scholar
Jewett A, Memarzadeh S, Kaur K, Commentary. Ovarian Cancer: path to effective treatments. Crit Reviews™ Immunol. 2025;45.
Hassanpour Khodaei S, Sabetkam S, Kalarestaghi H, Dizaji Asl K, Mazloumi Z, Bahramloo M, et al. Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction. Mol Biol Rep. 2025;52(1):1–17.
Zemanek T, Danisovic L, Nicodemou A. Exosomes, their sources, and possible uses in cancer therapy in the era of personalized medicine. J Cancer Res Clin Oncol. 2025;151(1):1–14.
Wang S, Wang J, Wei W, Ma G, Exosomes. The Indispensable Messenger in Tumor Pathogenesis and the rising star in Antitumor Applications. Adv Biosyst. 2019;3(5):e1900008.
Chen L, Lai L, Zheng L, Wang Y, Lu H, Chen Y. Construction of an exosome-associated miRNA-mRNA regulatory network and validation of FYCO1 and mir-17-5p as potential biomarkers associated with ovarian cancer. Translational Cancer Res. 2024;13(2):1052–67.
Di Bella MA. Overview and update on Extracellular vesicles: considerations on exosomes and their application in Modern Medicine. Biology (Basel). 2022;11(6).
Butreddy A, Kommineni N, Dudhipala N. Exosomes as naturally Occurring vehicles for Delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives. Nanomaterials (Basel). 2021;11(6).
Sojoudi K, Azizi H, Skutella T. A review of the potential of induced pluripotent stem cell-derived exosome as a novel treatment for male infertility. Biotechnol Genet Eng Rev. 2023:1–26.
Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011;12(12):1659–68.
Article CAS PubMed Google Scholar
de Gassart A, Géminard C, Hoekstra D, Vidal M. Exosome secretion: the art of reutilizing nonrecycled proteins? Traffic. 2004;5(11):896–903.
Essandoh K, Fan G-C. Insights into the mechanism of exosome formation and secretion. Mesenchymal Stem Cell Derived Exosomes. 2015:1–19.
Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75:193–208.
Article CAS PubMed Google Scholar
Ouyang X, Han X, Chen Z, Fang J, Huang X, Wei H. MSC-derived exosomes ameliorate erectile dysfunction by alleviation of corpus cavernosum smooth muscle apoptosis in a rat model of cavernous nerve injury. Stem Cell Res Ther. 2018;9:1–12.
Sarko DK, McKinney CE. Exosomes: origins and therapeutic potential for neurodegenerative disease. Front NeuroSci. 2017;11:246618.
Zhang L, Yu D. Exosomes in cancer development, metastasis, and immunity. Biochim Biophys Acta Rev Cancer. 2019;1871(2):455–68.
Article CAS PubMed PubMed Central Google Scholar
Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172(3):393–407.
Article CAS PubMed PubMed Central Google Scholar
Zamaraev AV, Volik PI, Sukhikh GT, Kopeina GS, Zhivotovsky B. Long non-coding RNAs: a view to kill ovarian cancer. Biochimica et Biophysica Acta (BBA) -. Reviews Cancer. 2021;1876(1):188584.
Beg A, Parveen R, Fouad H, Yahia M, Hassanein AS. Identification of driver genes and miRNAs in ovarian cancer through an integrated in-silico approach. Biology. 2023;12(2):192.
Article CAS PubMed PubMed Central Google Scholar
Ding Y, Huang X, Ji T, Qi C, Gao X, Wei R. The emerging roles of miRNA-mediated autophagy in ovarian cancer. Cell Death Dis. 2024;15(5):314.
Article CAS PubMed PubMed Central Google Scholar
Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73:2491–509.
Article CAS PubMed PubMed Central Google Scholar
Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochimica et Biophysica Acta (BBA)-Gene Regulatory mechanisms. 2014;1839(11):1097–109.
Duan J-j, Qiu W, Xu S-l, Wang B, Ye X-z, Ping Y-f, et al. Strategies for isolating and enriching cancer stem cells: well begun is half done. Stem Cells Dev. 2013;22(16):2221–39.
Article CAS PubMed PubMed Central Google Scholar
Xiao-da W. Comparison of the methods for isolating exosomes derived from human umbilical cord mesenchymal stem cells. Chin J Clin Lab Sci. 2014.
Ren Y, He J, Wang X, Liang H, Ma Y. Exosomes from adipose-derived stem cells alleviate premature ovarian failure via blockage of autophagy and AMPK/mTOR pathway. PeerJ. 2023;11.
Qu Q, Liu L, Cui Y, Liu H, Yi J, Bing W et al. Mir-126-3p containing exosomes derived from human umbilical cord mesenchymal stem cells promote angiogenesis and attenuate ovarian granulosa cell apoptosis in a preclinical rat model of premature ovarian failure. Stem Cell Res Ther. 2022;13.
Qu Q, Liu L, Cui Y, Chen Y, Wang Y, Wang Y. Exosomes from human omental adipose-derived mesenchymal stem cells secreted into Ascites promote peritoneal metastasis of epithelial ovarian Cancer. Cells. 2022;11(21):3392.
Article CAS PubMed PubMed Central Google Scholar
Chen J, Li P, Zhang T, Xu Z, Huang X, Wang R, Du L. Review on strategies and technologies for exosome isolation and purification. Front Bioeng Biotechnol. 2022;9:811971.
Article PubMed PubMed Central Google Scholar
Reza AMMT, Choi Y-J, Yasuda H, Kim J-H. Human adipose mesenchymal stem cell-derived exosomal-miRNAs are critical factors for inducing anti-proliferation signalling to A2780 and SKOV-3 ovarian cancer cells. Sci Rep. 2016;6(1):38498.
Article CAS PubMed PubMed Central Google Scholar
Shigeyasu K, Toden S, Zumwalt TJ, Okugawa Y, Goel A. Emerging role of microRNAs as liquid biopsy biomarkers in gastrointestinal cancers. Clin Cancer Res. 2017;23(10):2391–9.
Article CAS PubMed PubMed Central Google Scholar
Giannopoulou L, Zavridou M, Kasimir-Bauer S, Lianidou ES. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes. Translational Res. 2019;205:77–91.
Zhao Z, Yang Y, Zeng Y, He M. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip. 2016;16(3):489–96.
留言 (0)